Literature DB >> 24596015

Immunoglobulin heavy chain/light chain pairs (HLC, Hevylite™) assays for diagnosing and monitoring monoclonal gammopathies.

Maria Kraj1.   

Abstract

Immunofixation (IFE) is a standard method for detecting monoclonal immunoglobulins and characterizing its isotype. Recently clonality can also be determined by using immunoglobulin (Ig) heavy chain/light chain immunoassays - HLC, HevyliteTM. HLC separately measures in pairs light chain types of each intact Ig class generating ratios of monoclonal Ig/uninvolved polyclonal Ig concentrations. Studies have shown that HLC and IFE are complementary methods. HLC assays quantify monoclonal proteins and identify monoclonality. It is possible to predict prognosis in multiple myeloma and to monitor response to treatment using HLC ratio. HLC ratio may serve as a parameter for myeloma induced immunoparesis and serve as a new marker for validating remission depth and relapse probabilities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24596015     DOI: 10.17219/acem/37036

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  3 in total

Review 1.  What we mean when we talk about MRD in myeloma. A review of current methods. Part 1 of a two-part series.

Authors:  Scott Ely; Noa Biran; Ajai Chari
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

Review 2.  The Evolution of Prognostic Factors in Multiple Myeloma.

Authors:  Amr Hanbali; Mona Hassanein; Walid Rasheed; Mahmoud Aljurf; Fahad Alsharif
Journal:  Adv Hematol       Date:  2017-02-21

3.  Analysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple Myeloma.

Authors:  Haiwei Du; Linyue Wang; Bo Liu; Jinying Wang; Haoxiang Su; Ting Zhang; Zhongxia Huang
Journal:  Front Pharmacol       Date:  2018-08-22       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.